A case for annual mammography screening

C. Printz

DOI: https://doi.org/10.1002/cncr.27500

IF: 6.9209

2012-03-15

Cancer

Abstract:

What problem does this paper attempt to address?

Results of Atypical Hemifacial Spasm with Microvascular Decompression: 14 Case Reports and Literature Review

Hua Zhao,Xin Zhang,Ying Zhang,Yin-Da Tang,Jin Zhu,Xu-Hui Wang,Ting-Ting Ying,Shi-Ting Li

DOI: https://doi.org/10.1016/j.wneu.2017.06.030

Abstract:Background: Few studies have examined atypical hemifacial spasm (AHFS), and the mechanism of AHFS remains unclear. In this study, we examined the etiology, prognosis, and treatment of AHFS. Methods: We retrospectively analyzed the clinical data for 14 consecutive patients that underwent microvascular decompression (MVD) for AHFS between January 2014 and December 2015. Clinical features, outcomes, and complications were evaluated. Results: The incidence of AHFS is 1.52%. There were no significant differences in sex, age, side and duration between the typical hemifacial spasm and AHFS. During the follow-up period, the effective rate of MVD for patients with AHFS was 92.3%. Three patients developed delayed facial nerve palsy postoperatively, 1 patient experienced occipital sensory disturbance, and 1 patient suffered hearing loss. Conclusions: Most of the cases of AHFS studied here were caused by neurovascular conflict in zone IV of the facial nerve distal to the root entry zone. MVD surgery is the first choice treatment for AHFS.
Microvascular Decompression for Hemifacial Spasm Associated with Distinct Offending Vessels: A Retrospective Clinical Study

Chengrong Jiang,Weibang Liang,Jing Wang,Yuxiang Dai,Wei Jin,Xiaoyang Sun,Wu Xu

DOI: https://doi.org/10.1016/j.clineuro.2020.105876

IF: 1.885

2020-01-01

Clinical Neurology and Neurosurgery

Abstract:OBJECTIVE:To investigate the surgical effects and complications of microvascular decompression (MVD) for hemifacial spasm (HFS) based on different offending vessels, and report our surgical experience of HFS patients related to vertebral artery.PATIENTS AND METHODS:MVDs performed in Nanjing Drum Tower Hospital between January 1, 2014 and December 31, 2017 were retrospectively studied, and 1152 patients with HFS were split into two groups in accordance with the offending vessels.RESULTS:954 patients with HFS caused by small vascular compression were classified as Group A. 849 patients got cured immediately after MVD, while delayed resolution was identified in 101 patients. 4 patients were not relieved and 4 were relapsed during the follow-up period. We observed 76 cases of delayed facial paralysis, 7 cases of hearing loss, 2 hoarseness and 3 cases of CSF leakage after surgery. In Group B, 198 patients displayed HFS associated with the vertebral artery (VA). 144 cases were spasm free after surgery and 51 patients had a delayed resolution. 3 patients were not significantly ameliorated and 2 were relapsed during the follow-up period. The major postoperative complications included facial paralysis in 28 patients, hearing loss in 4 and hoarseness and dysphagia in 3. The two groups showed no operative death.CONCLUSIONS:For the patients with HFS related to VA, the delayed cure rate and the incidence of postoperative cranial nerve complications were higher than HFS attributed to small vascular compression. And the two groups were not different in the long-term outcome and the incidence of permanent cranial nerve complications.
Collaboration for quality improvement: understanding the process improvement cycle.

R. Salcido

DOI: https://doi.org/10.1097/01.ASW.0000437788.77282.0c

IF: 2.3729

2013-12-01

Advances in Skin & Wound Care

Abstract:This month’s continuing education activity on ‘‘Improving Processes to Capture Present on AdmissionsYPressure Ulcers’’ (page 566) is an opportune time to discuss quality improvement. The task of improving processes requires use of data input by gathering qualitative or quantitative intelligence about the problem to be solved or process to be improved. The data collected can be used for process improvement by observing and measuring and evaluating processes of wound care delivery through improvement in safety, cost, efficiency or better clinical outcomes and enhanced quality of life for the persons served. Many process improvement theories in the manufacturing world have been adopted andmodified in healthcare, such as the use of ‘‘quality improvement bundles.’’ In this context, the term bundling should not be confusedwith finance processes used to process payments for services provided.However, costmust be factored into any equation of quality measures.
Microvascular Decompression for Hemifacial Spasm after Bell’s Palsy: a Retrospective Clinical Study

Chengrong Jiang,Jing Wang,Yulong Chong,Wu Xu,Weibang Liang

DOI: https://doi.org/10.1007/s10143-024-02328-w

IF: 2.8

2024-01-01

Neurosurgical Review

Abstract:Objective This study aimed to investigate the clinical characteristics of hemifacial spasm (HFS) after Bell’s palsy and to evaluate the therapeutic efficacy of microvascular decompression (MVD). Methods A retrospective analysis was conducted on 18 patients who underwent MVD for HFS after Bell’s palsy at our institution between January 1, 2017, and December 31, 2021. Clinical presentations, intraoperative findings, postoperative outcomes, and complications were comprehensively assessed. Results Neurovascular compression (NVC) was identified in all the 18 patients. The offending vessels included anterior inferior cerebellar artery (AICA) in 6 patients (33.3%), posterior inferior cerebellar artery (PICA) in 7 patients (38.9%), vertebral artery (VA) combined with AICA in 3 patients (16.7%), and VA alongside PICA in 2 patients (11.1%). Notably, marked arachnoid membrane adhesion was evident in 11 patients (61.1%). 15(83.3%) patients were cured immediately after MVD, delayed relief was found in 3 (16.7%) patients. During the follow-up period, recurrence was not documented. Surgical complications were limited to facial paralysis in 3 patients and auditory impairment in 1 patient. No additional surgical complications were recorded. Conclusions In patients manifesting HFS after Bell’s palsy, NVC predominantly underlies the etiology. MVD is a reliably safe and efficacious therapeutic intervention.
Microvascular Decompression Surgery for Hemifacial Spasm

Hongwu Qi,Weining Zhang,Xudong Zhang,Caixia Zhao

DOI: https://doi.org/10.1097/SCS.0000000000002306

Abstract:Objective: This study aims to investigate the operative efficacy, surgical complication rate, and surgical strategy of microvascular decompression (MVD) for hemifacial spasm (HFS). Methods: Clinical data of 46 patients with HFS who underwent MVD were retrospectively analyzed. Results: During surgery, it was found that the facial nerve root exit zone was compressed by the following arterial vessels: anterior inferior cerebellar artery in 24 patients (52.17%); posterior inferior cerebellar artery in 14 patients (30.43%); vertebral artery and a small artery in 7 patients (15.22%); and vertebral artery in 1 patient (2.18%). Symptoms of 38 patients were immediately remitted completely after surgery and symptoms of 8 patients were significantly reduced. Main complications included dizziness and tinnitus in 9 patients, hearing loss in 5 patients, cerebrospinal fluid leakage in 1 patient, and infection in 2 patients. No patient died during surgery. Conclusions: MVD is the preferred choice for treating idiopathic hemifacial spasm, and hearing impairment is the main complication. Skilled microsurgical techniques, as well as identifying and completely decompressing offending vessels, are the key to ensuring a successful microvascular decompression.
Computer-assisted 3D analysis of cell distributions in the normal and epileptic cerebral cortex: description of a methodology in progress.

R. Pascher,C. Berthold,M. Rydmark,T. Skoglund,T. Jansson,T. Gustavsson

DOI: https://doi.org/10.1016/0895-6111(93)90035-L

IF: 7.422

1993-07-01

Computerized Medical Imaging and Graphics

Abstract:
A comparative study of intraoperative findings and postoperative outcomes between atypical and typical hemifacial spasms

MingXing Liu,Lei Xia,Jun Zhong,Bin Li,NingNing Dou,ShiTing Li

DOI: https://doi.org/10.1007/s10143-017-0898-9

Abstract:In most hemifacial spasm cases, the spasm initiates from the orbicularis occuli muscle and gradually spreads downwards to the orbicularis oris and buccinator muscles. Seldomly, the spasm might start from the orbicularis oris and buccinator muscles and develop upwards, which has been called as atypical hemifacial spasm (aHFS). Until now, little is known about its pathogenesis and the efficacy of microvascular decompression (MVD) surgery. We reviewed 1935 HFS cases undergoing MVD between 2007 through 2016. Among them, 15 were diagnosed as aHFS, whom were focused on. Their intraoperative findings and postoperative outcomes were compared with those typical hemifacial spasm (tHFS) cases. In the aHFS group, the conflict site was found in the root exit zone (REZ) in 12 (rostral 9, dorsal 2, and ventral 1) and in the cisternal segment in 3. In the tHFS group, the conflict site was found in the REZ in 1812 (rostral 6, caudal 1734, dorsal 12, and ventral 60) and in the cisternal segment in 108. The rostral REZ seemed to be the most frequent neurovascular conflict site in aHFS compared to the caudal REZ in tHFS (p < 0.05). Postoperatively, the effective rate of MVD was 93.3% in the aHSF group, while 96.3% in the tHSF group (p > 0.05). It was demonstrated that MVD may also lead to a satisfactory outcome for aHFS. Although the caudal REZ of the facial nerve is a frequent conflict site for most of the hemifacial spasm cases, the rostral side or cisternal segment of the facial nerve root should not be ignored while searching for the offending artery.
Analysis of Postoperative Complications of Microvasular Decompression for Hemifacial Spasm

Ni Hongbin,Liang Weibang,Yao Liang

2009-01-01

Abstract:Objective To investigate the causes and therapy of complications of microvascular decompression (MVD) for hemifacial spasm (HFS). Method Totally 255 cases of HFS underwent MVD in our hospital from December 2000 to March 2000. Among the cases,207 patients were followed up for more than 1 year,the occurrence and recovery of their postoperative complications were reviewed in this study. Results In this series,no patient died;cerebrospinal fluid leakage was detected in 15 patients (7.2%) in one week after the operation;facial palsy occurred in 48 cases (23.2%);hearing deficit was shown in 20 patients (9.7%);and tinnitus was found in 12 cases (5.8%). The patients were followed up for 1 to 7.3 years with a mean of (4.2±2.7) years,during the period,none of the cases had cerebrospinal fluid leakage or intracerebral infection,and the cases who had facial palsy and tinnitus recovered completely;only 10 patients remained hearing deficit (including unilateral deaf in 6) during the follow-up.Conclusion Cerebrospinal fluid leakage,facial palsy,hearing deficit,tinnitus are the major complications of MVD,among which cerebrospinal fluid leakage,facial palsy,and tinnitus can be improved after treatments,but hearing deficit is non-reversible.
Microvascular decompression for hemifacial spasm: A systematic review of vascular pathology, long term treatment efficacy and safety

Ravi Sharma,Kanwaljeet Garg,Samagra Agarwal,Deepak Agarwal,P Sarat Chandra,Shashank S Kale,Bhawani S Sharma,Ashok K Mahapatra

DOI: https://doi.org/10.4103/neuroindia.NI_1166_16

Abstract:Introduction: Hemifacial spasm (HS) is a rare disorder caused by the compression of facial nerve root exit zone (REZ) at the brainstem by a vascular loop. Microvascular decompression (MVD) is a popular treatment modality for HS. Objective: The purpose of this study was to determine the long-term efficacy and safety of MVD for HS by assessing the effect of the procedure from the literature published over the last 25 years. Materials and methods: A systematic data review from 1992 to 2015 using specific eligibility criteria yielded 27 studies on MVD for HS, the data of which were pooled and subjected to a meta-analysis. Results: The pooled odds ratio (OR) revealed by the meta-analysis showed that anterior inferior cerebellar artery was the most common offending vessel in 37.8% (95% confidence interval [CI]: 27.8-47.7%) of the patients. Complete resolution of HS was seen in 88.5% (95% CI: 86.7-90.4%) of the patients after a long-term follow up. The complication rate was low following MVD, the most common being temporary facial paresis in 5.9% (95% CI: 4.3-7.5%) of patients. Conclusions: MVD is a safe and effective treatment for HS with long-term benefits and a low complication rate.
How to Improve the Effect of Microvascular Decompression for Hemifacial Spasm: A Retrospective Study of 32 Cases with Unsuccessful First Time MVD

Yun-Fei Xia,Wei-Ping Zhou,Ying Zhang,Yan-Zhen Li,Xu-Hui Wang,Shi-Ting Li,Hua Zhao

DOI: https://doi.org/10.1055/s-0041-1735855

Abstract:Background: Microvascular decompression (MVD) has become accepted as an effective therapeutic option for hemifacial spasm (HFS); however, the curative rate of MVD for HFS varies widely (50-98%) in different medical centers. This study could contribute to the improvement of the MVD procedure. Methods: We retrospectively analyzed 32 patients in whom initial MVD failed in other hospitals and who underwent a second MVD at our center. The clinical characteristics, operative findings, outcome of the second MVD, and complications were recorded. Results: There were 18 women and 14 men (56.3 and 43.7%, respectively). The left-to-right ratio was 19:13. The mean age of the patients was 59.8 years. We found an undiscovered conflict site located in zone 4 in 10 patients and in the root entry zone in 8 patients. The initial MVD failed in nine patients because of ignorance of the arterioles that originate from the anterior inferior cerebellar artery. There were no special findings in four patients. No Teflon felts were found in the whole surgical field in one patient. Conclusion: Omission of the offending vessel is the most common cause of an unsuccessful MVD. Intraoperative abnormal muscle response associated with the Z-L response is a good measure to correctly identify the involved arterioles.
Microvascular decompression for hemifacial spasm involving the vertebral artery

Jing Wang,Yulong Chong,Chengrong Jiang,Yuxiang Dai,Weibang Liang,Lianshu Ding

DOI: https://doi.org/10.1007/s00701-021-05076-8

Abstract:Objective: Microvascular decompression (MVD) has become an accepted treatment modality for the vertebral artery (VA)-involved hemifacial spasm (HFS). The aim of this retrospective study was to evaluate clinical and surgical outcomes of HFS patients undergoing MVD and surgical and cranial nerve complications and investigate reasonable transposition procedures for two different anatomic variations of VA. Methods: Between January and December 2018, 109 patients underwent first MVD for HFS involving VA at Nanjing Drum Tower Hospital. Based on whether the VA could be moved ventrally at the lower cranial nerves (LCNs) level, patients were assigned to Group A (movable VA, n = 72) or B (unmovable VA, n = 37), and clinical and surgical outcomes and complications on the day of post-surgery and during follow-up were assessed. All patients were followed up ranging from 17 to 24 months with a mean follow-up period of 21 months. Results: After a mean follow-up of 21 months, the total cure rate significantly decreased in all patients compared to that achieved on the day of surgery, and Group A patients exhibited a higher cure rate versus Group B (93.1% vs. 75.7%, P = 0.015). Group B patients with unmovable VA revealed both higher incidence of surgical complications (45.9% vs. 15.3%, P = 0.001) and frequency of bilateral VA compression (27% vs. 8.3%, P = 0.009) versus Group A. No significant difference was observed in long-term cranial nerve complications. Conclusions: VA-involved HFS can benefit from MVD strategies after preoperative assessment of VA compression. HFS patients with movable VA may receive better long-term efficacy and fewer complications. A Teflon bridge wedged between the distal VA and medulla gives rise to adequate space for decompression surgery.
Shiga toxins and stx phages: highly diverse entities.

Alejandra Krüger,P. Lucchesi

DOI: https://doi.org/10.1099/mic.0.000003

2015-03-01

Microbiology

Abstract:Shiga toxins are the main virulence factors of a group of Escherichia coli strains [Shiga toxin-producing E. coli (STEC)] that cause severe human diseases, such as haemorrhagic colitis and haemolytic-uraemic syndrome. The Shiga toxin family comprises several toxin subtypes, which have been differentially related to clinical manifestations. In addition, the phages that carry the Shiga toxin genes (stx phages) are also diverse. These phages play an important role not only in the dissemination of Shiga toxin genes and the emergence of new STEC strains, but also in the regulation of Shiga toxin production. Consequently, differences in stx phages may affect the dissemination of stx genes as well as the virulence of STEC strains. In addition to presenting an overview of Shiga toxins and stx phages, in this review we highlight current knowledge about the diversity of stx phages, with emphasis on its impact on STEC virulence. We consider that this diversity should be taken into account when developing STEC infection treatments and diagnostic approaches, and when conducting STEC control in reservoirs.
Long-term outcome of microvascular decompression for hemifacial spasm

Ming-Yi Lv,Shu-Ling Deng,Xiao-Feng Long,Zeng-Liang Liu

DOI: https://doi.org/10.1080/02688697.2017.1297368

Abstract:Aim: To investigate the long term outcomes of microvascular decompression (MVD) for hemifacial spasm (HFS) and to identify any prognostic factors. Methods: A retrospective analysis of 189 consecutive patients with typical HFS who underwent MVD. Multiple logistic regression analysis of variables at various time points including at least immediate time point and one at no less than six years was performed. Results: Short-term follow-up showed a cure rate of 91%, including 51 cases of delayed resolution (27%). At two years or more information was available in 148 (out of 189) cases of patients. 101 cases (68% - of 148 cases) had complete recovery, 28 cases (19%) achieved a partial though worthwhile recovery, so that the effective rate of symptoms relief at six years was 87%. Complications were found (66/189, 34.92%) and cured within the follow-up period (cure rate of 100%). In both the univariate and multivariate analyses, the postoperative findings of clinical outcomes showed that preoperative illness duration, compressive pattern, the intraoperative indentation of the root exit zone (REZ) of the facial nerve and intraoperative AMR disappearance were negative predictors and age considered to be positive, which significantly predicted the clinical outcome of patients following MVD. Conclusions: MVD may be a safe and effective strategy for HFS patients in view of relatively higher cure rates and lower complication risks within follow-up. Besides, patients' age, duration of disease, intraoperative indentation of the REZ of the facial nerve, and disappearance of AMR were the major influential variables may be useful for the prediction of prognosis in the patients underwent MVD.
Microvascular decompression in patients with hemifacial spasm

Xuegang Niu,Hongtao Sun,Fei Yuan,Xuyi Chen,Zhengjun Wei,Hang Wang,Jibin Ren,Jian Zhang,Weixin Li

DOI: https://doi.org/10.1002/brb3.1432

Abstract:Purpose: To study blood pressure alterations after microvascular decompression (MVD) surgery in patients with hemifacial spasm (HFS). Methods: A retrospective study was performed to review HFS patients who received MVD surgery between January 2014 and December 2016. Vessels that were considered to be responsible for HFS were determined by reviewing the brain magnetic resonance imaging, magnetic resonance angiography, and surgical video. Blood pressure measurements were performed 1 day before (preoperative) and 7 days after (postoperative) the MVD surgery. Pre- and postoperative blood pressure measurements were compared. Results: A total of 374 patients were included in the study, with 118 (31.6%) male patients, age 53.8 ± 9.9 years old, and 141 (37.7%) patients with hypertension. Systolic blood pressure had statistically significant decrease in patients with (134.5 ± 8.2-132.6 ± 9.1 mmHg, p = .01) or without (125.6 ± 9.1-123.8 ± 10.0 mmHg, p = .01) hypertension. Diastolic blood pressure only had statistically significant decrease in patients with hypertension (83.0 ± 5.8-82.0 ± 6.5 mmHg, p = .04). Analyses in all the study patients and in the subgroup of patients with hypertension showed that more statistically significant blood pressure reductions were observed when left-side vessel or vertebrobasilar artery was involved. Conclusion: In patients with HFS, MVD not only decreased blood pressure in patients with hypertension but also affected blood pressure in patients without hypertension. Blood pressure reductions were more prominent when left-side vessel or vertebrobasilar artery was involved.
[An analysis of clinical efficacy of microvascular decompression for 21 inpatients suffering from primary hemifacial spasm]

Lina Gong,Dongzhen Yu,Yaqin Wu,Zhengnong Chen,Shankai Yin

DOI: https://doi.org/10.13201/j.issn.2096-7993.2024.05.004

Abstract:Objective:To assess the effectiveness of microvascular decompression（MVD） in treating inpatients suffering from primary hemifacial spasm（HFS）. Methods:A total of 21 inpatients with HFS underwent MVD. The clinical effect was follow up evaluated according to the clinical symptoms until post operative 6 months. Results:The effective rate of MVD for 1 day, 14 days, 1 month, 3 months and 6 months post-operation was 95.2%, 100%, 100%, 100% and 100%, respectively.one patient had transient tinnitus and the symptom disappeared within 6 days postoperatively.one patient developed postoperative incomplete facial paralysis（HB grade IV facial nerve function, grade Ⅱ） and recovered 6 days after surgery; There was no cerebrospinal fluid leakage, intracranial infection, death or disability occurred during follow-up. Conclusion:Microvascular decompression is a safe and effective method for the treatment of primary hemifacial spasm, which is worthy of clinical promotion.
Clinical analysis of hemifacial spasm patients with delay symptom relief after microvascular decompression of distinct offending vessels

Yuxiang Dai,Hongbin Ni,Wu Xu,Tianyu Lu,Weibang Liang

DOI: https://doi.org/10.1007/s13760-015-0471-7

2015-01-01

Acta Neurologica Belgica

Abstract:This study investigates symptom relief in patients whose hemifacial spasms (HFS) were completely relieved following microvascular decompression (MVD). Patients with HFS who were operated on from January 2007 to May 2011, at our department, were studied. The medical records and operation videos of each patient were reviewed. Follow-up was performed via telephone communication. A total of 410 patients with HFS were divided into two groups: Group A (277 cases): HFS caused by small vascular compression, and Group B (133 cases): HFS caused by vertebral artery compression. Magnetic resonance imaging (MRI) was performed on all the patients to rule out those with secondary HFS. Patients who had undergone previous MVD were also excluded at that time. In all, 462 patients underwent MVD for HFS in our center during the study period. Follow-up was available for 410 patients. In the small vascular compression cohort, 72 (72/277, 26.0 %) HFS patients achieved relief with delayed healing. While in the vertebral artery compression cohort, 52 (52/133, 39.1 %) HFS patients experienced relief with delayed healing. There was significant difference between these two cohorts ( P < 0.05). 93.75% of delayed healing patients were cured and experienced spasm relief within 6 months. Surgeons should be aware that delayed symptom relief after MVD for HFS is more common than has been reported, and time course of symptom relief is various as well as unpredictable; however, most HFS patients are cured, and experience spasm relief within 6 months.
Outcomes after Microvascular Decompression for Hemifacial Spasm without Definite Radiological Neurovascular Compression at the Root Exit Zone

Chiman Jeon,Minsoo Kim,Hyun-Seok Lee,Doo-Sik Kong,Kwan Park

DOI: https://doi.org/10.3390/life13102064

2023-10-16

Abstract:The purpose of this study was to investigate the outcome of microvascular decompression (MVD) in patients with hemifacial spasm (HFS) who have no definite radiological neurovascular compression (NVC). Sixteen HFS patients without radiological NVC on preoperative MRI underwent MVD surgery. The symptoms were left-sided in fourteen (87.5%) and right-sided in two patients (12.5%). Intraoperatively, the most common vessel compressing the facial nerve was the AICA (8, 44.4%), followed by arterioles (5, 27.8%), veins (4, 22.2%), and the PICA (1, 5.6%). The most common compression site was the cisternal portion (13, 76.5%) of the facial nerve, followed by the REZ (4, 23.5%). One patient (6.3%) was found to have multiple NVC sites. Arachnoid type (7, 50%) was the most common compressive pattern, followed by perforator type (4, 28.6%), sandwich type (2, 14.3%), and loop type (1, 7.1%). A pure venous compression was seen in two patients, while a combined venous-arterial "sandwich" compression was detected in two patients. Symptom improvement was observed in all of the patients. Only one patient experienced recurrence after improvement. Based on our experience, MVD surgery can be effective for primary HFS patients with no definite radiological NVC. MVD can be considered if the patient shows typical HFS features, although NVC is not evident on MRI.
Fully endoscopic microvascular decompression for hemifacial spasm: a clinical study and analysis

Xialin Zheng,Binbin Zhang,Dongqi Shao,Longjie Cai,Shan Xie,Yu Li,Zhiquan Jiang

DOI: https://doi.org/10.1007/s10143-024-02311-5

2024-02-16

Abstract:Fully endoscopic microvascular decompression (MVD) of the facial nerve is the main surgical treatment for hemifacial spasm. However, the technique presents distinct surgical challenges. We retrospectively analyzed prior cases to consolidate surgical insights and assess clinical outcomes. Clinical data from 16 patients with facial nerve spasms treated at the Department of Neurosurgery in the First Affiliated Hospital of Bengbu Medical College, between August 2020 and July 2023, were retrospectively examined. Preoperatively, all patients underwent magnetic resonance angiography to detect any offending blood vessels; ascertain the relationship between offending vessels, facial nerves, and the brainstem; and detect any cerebellopontine angle lesions. Surgery involved endoscopic MVD of the facial nerve using a mini Sigmoid sinus posterior approach. Various operative nuances were summarized and analyzed, and clinical efficacy, including postoperative complications and the extent of relief from facial paralysis, was evaluated. Fully endoscopic MVD was completed in all patients, with the offending vessels identified and adequately padded during surgery. The offending vessels were anterior inferior cerebellar artery in 12 cases (75%), vertebral artery in 3 cases (18.75%), and posterior inferior cerebellar artery in 1 case (6.25%). Intraoperative electrophysiological monitoring revealed that the lateral spread response of the facial nerve vanished in 15 cases and remained unchanged in 1 case. Postoperative facial spasms were promptly alleviated in 15 cases (93.75%) and delayed in 1 case (6.25%). Two cases of postoperative complications were recorded-one intracranial infection and one case of tinnitus-both were resolved or mitigated with treatment. All patients were subject to follow-up, with no instances of recurrence or mortality. Fully endoscopic MVD of the facial nerve is safe and effective. Proficiency in endoscopy and surgical skills are vital for performing this procedure.
Endoscope-assisted Microvascular Decompression of the Hemifacial Spasm

ZHU Wei,ZHANG Xiao-Biao,ZHANG Yu,HU Fan,YU Yong

DOI: https://doi.org/10.3969/j.issn.1008-0678.2011.01.006

2011-01-01

Abstract:Aim:To summarize the clinical experience in the treatment of hemifacial spasm (HFS) with microvascular decompression (MVD). Methods:A retrospective study was performed by using the patient samples in 258 cases from 2004 to 2010. Suboccipital retrosegmoid approach was used in microsurgery and assisted by endoscope. Results:MVD was effective in 256 cases(99.2%) with no surgical death or major deficit. The excellent and good were 251(97.3%) and 5 (1.9%),respectively. The majority (58.9%) of affecting vessels was anterior interior cerebellar artery (AICA). Neurological complications were 28 cases(10.9%),which were hearing deficit(n=13),facial weakness(n=8),tinnitus(n=3),diplopia(n=1),deglutiton weakness(n=1),cerebrospinal leaking(n=2). Conclusion:MVD of the facial nerve is an effective and reliable treatment for HFS. Meanwhile,using of endoscopic vascular decompression is a safe and equally effective procedure,which can increase operative accuracy and decrease operative side-effect.
Clinical Characteristics and Efficacy of Microvascular Decompression for Young Onset Hemifacial Spasm Patients

Jiang Chengrong,Ni Hongbin,Dai Yuxiang,Xuwu,Liang Weibang

DOI: https://doi.org/10.3760/cma.j.issn.1001-2346.2015.03.013

2015-01-01

Abstract:Objective To investigate the clinical characteristics,causes and surgical treatment of young onset hemifacial spasm patients.Methods A total of 982 patients underwent microvascular decompression (MVD) for hemifacial spasm (HFS) in Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School from January,2010 to December,2013.17 patients with the onset age ≤22 years old were analyzed retrospectively.Results Among the 17 unilateral HFS patients,4 were males and 13 were females.The mean age of onset was [19.4 ±2.3(14-22)] years.The mean duration before operation was [5.5 ± 3.0 (1-11)] years.The preoperative MRI showed that the average outside diameter of the offending vessels was (1.66 ± 0.81) mm,the average angle of the posterior fossa was (29.92 ± 4.78) °.The offending arteries were observed in all patients.The local anatomic variations and exceptional arteries were found in 14 patients.16 patients got a clinical resolution,of which 14 cases were cured immediately,delayed resolution (1,3 months after surgery) was found in two cases,without recurrence during the follow-up period(1-3 years).One patient relapsed 10 d after the surgery.One case of delayed facial paralysis (14 days after surgery) and one hoarseness were observed.Conclusions Young onset HFS patients were rare.Exceptional arteries and anatomic structural variation might be the main causes of this disease.MVD had good effect.

A case for annual mammography screening

Results of Atypical Hemifacial Spasm with Microvascular Decompression: 14 Case Reports and Literature Review

Microvascular Decompression for Hemifacial Spasm Associated with Distinct Offending Vessels: A Retrospective Clinical Study

Collaboration for quality improvement: understanding the process improvement cycle.

Microvascular Decompression for Hemifacial Spasm after Bell’s Palsy: a Retrospective Clinical Study

Microvascular Decompression Surgery for Hemifacial Spasm

Computer-assisted 3D analysis of cell distributions in the normal and epileptic cerebral cortex: description of a methodology in progress.

A comparative study of intraoperative findings and postoperative outcomes between atypical and typical hemifacial spasms

Analysis of Postoperative Complications of Microvasular Decompression for Hemifacial Spasm

Microvascular decompression for hemifacial spasm: A systematic review of vascular pathology, long term treatment efficacy and safety

How to Improve the Effect of Microvascular Decompression for Hemifacial Spasm: A Retrospective Study of 32 Cases with Unsuccessful First Time MVD

Microvascular decompression for hemifacial spasm involving the vertebral artery

Shiga toxins and stx phages: highly diverse entities.

Long-term outcome of microvascular decompression for hemifacial spasm

Microvascular decompression in patients with hemifacial spasm

[An analysis of clinical efficacy of microvascular decompression for 21 inpatients suffering from primary hemifacial spasm]

Clinical analysis of hemifacial spasm patients with delay symptom relief after microvascular decompression of distinct offending vessels

Outcomes after Microvascular Decompression for Hemifacial Spasm without Definite Radiological Neurovascular Compression at the Root Exit Zone

Fully endoscopic microvascular decompression for hemifacial spasm: a clinical study and analysis

Endoscope-assisted Microvascular Decompression of the Hemifacial Spasm

Clinical Characteristics and Efficacy of Microvascular Decompression for Young Onset Hemifacial Spasm Patients